Archives

  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • Luo H Ge H Cui

    2020-08-06

    [16] Luo H, Ge H, Cui Y, Zhang J, Fan R, Zheng A, et al. Systemic AT13387 biomarkers predict survival in patients of early stage non-small cell lung cancer treated with stereotactic ablative radiotherapy - a single center experience. J Cancer 2018;9(1):182e8.
    [17] Roxburgh CSD, McMillan DC. Re: comparison of the prognostic value of inflammation based pathological and biochemical criteria in patients under-going potentially curative resection for colorectal cancer (letter). Ann Surg 2010;251(2):390e1.
    [19] Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20(1):1e19. [20] Ajani Jaffer A, D'Amico Tomas A, Almhanna Khaldoun, Chao Joseph, Das Prajnan, Denlinger Crystal S, et al. Stomach. In: Amin MB, editor. AJCC cancer staging manual. eighth ed. New York: Springer-Verlag; 2016. [21] Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373e83. [22] Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Can-cer Res 2004;10(21):7252e9.
    [23] He C, Zhang Y, Cai Z, Duan F, Lin X, Li AT13387 S. Nomogram to predict cancer-specific survival in patients with pancreatic acinar cell carcinoma: a competing risk analysis. J Cancer 2018;9(22):4117e27. [24] Pages F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, et al. International validation of the consensus Immunoscore for the classification of colon can-cer: a prognostic and accuracy study. Lancet 2018;391(10135):2128e39. [25] Yu J, Hu J, Huang C, Ying M, Peng X, Wei H, et al. The impact of age and co-morbidity on postoperative complications in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: results from the Chinese laparo-scropic gastrointestinal surgery study (CLASS) group. Eur J Surg Oncol 2013;39(10):1144e9.
    Please cite this article as: Lin J-X et al., Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy, European Journal of Surgical Oncology, https://doi.org/10.1016/j.ejso.2019.07.010
    8 J.-X. Lin et al. / European Journal of Surgical Oncology xxx (xxxx) xxx
    [28] Albert A, Lee A, Allbright R, Vijayakumar S. Impact of age on receipt of curative treatment for cervical cancer: an analysis of patterns of care and survival in a large, national cohort. J Geriatr Oncol 2019;10(3):465e74.
    [29] Liu K, Wang P, Zhu X, Bei Y, Zheng Z, Yan S. Disparities of age-based cancer-specific survival improvement with various clinicopathologic characteristics for kidney cancer. Cancer Manag Res 2018;10:2259e68. [30] Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, et al. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell 2012;11(5):912e5.
    [31] Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014;15(11):e493e503. [32] Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W, et al. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 2017 Sep;111:176e81.
    [33] Kao HK, Lofstrandā‚¬ J, Loh CY, Lao WW, Yi JS, Chang YL, et al. Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma. Sci Rep 2018;8(1): 13081.
    [34] Chan JY, Zhang Z, Chew W, Tan GF, Lim CL, Zhou L, et al. Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio
    [35] Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immuno-surveillance and immunoediting. Immunity 2004;21(2):137e48. [36] Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol 2012;30:2678e83.
    [37] Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, et al. Prog-nostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer. Ann Surg; 2018 [Epub ahead of print]. ~ [38] Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106(6). dju124.